My activities on LinkedIn reflect my values, interests and opinions and are not necessarily representative of those of my current employer.
Dr Laura Issa is responsible for implementing the business development and external partnerships strategy across Australia and New Zealand for AbbVie Inc., a global specialty biopharmaceutical company. In this capacity, Laura engages with companies, entrepreneurs, scientists and investors across the biopharma and medtech innovation ecosystem to bridge connectivity with AbbVie scientists. Laura’s ultimate mission is to build collaborative research partnerships, licensing opportunities and venture investments that align with AbbVie’s areas of interest, covering immunology, oncology, neuroscience, eye care, women’s health and virology.
Laura is also passionate about enabling healthcare innovation and achieving equitable access to medicines with quality use of medicines. Laura is proud to partner with stakeholders to enable the innovation process, in ways that prime the pipeline and ensure we create lasting impact for the Australian economy and for patients. She achieves this through active participation on various industry advisory committees and skills-building initiatives, including the Bridge Program and SBE Australia.
Laura bridges science and business, having had over 20 years’ experience across the academic, biotechnology and pharmaceutical sectors, at all stages of the product life cycle. Laura is especially skilled at building value-based partnerships that advance medical research and innovation.